Webform

Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name
ZERO Summit 2021 banner

What You Need to Know About Oral ADT

A man sitting at a kitchen table looking at pills

The option of an androgen deprivation therapy (ADT) being administered orally could have a significant impact on the lifestyle of a man with prostate cancer. 

Doctor Daniel George, a medical oncologist at Duke Cancer Center, shares advancements in androgen deprivation therapy (ADT). In this video, you'll learn more about oral ADT treatments and how they might differ from injectable ADT treatment.

This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.


Watch

Contributors

Daniel George MD Headshot
Daniel George, MD, Medical Oncologist

Daniel George specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer.

Shelby Moneer Headshot
Shelby Moneer, Vice President, Patient Programs & Education

Shelby Moneer was the Vice President of Patient Programs & Education at ZERO Prostate Cancer until April 2025.

Share